Your browser doesn't support javascript.
loading
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial.
DiSilvestro, Paul; Banerjee, Susana; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla; Floquet, Anne; Leary, Alexandra; Sonke, Gabe S; Gourley, Charlie; Oza, Amit; González-Martín, Antonio; Aghajanian, Carol; Bradley, William; Mathews, Cara; Liu, Joyce; McNamara, John; Lowe, Elizabeth S; Ah-See, Mei-Lin; Moore, Kathleen N.
Afiliación
  • DiSilvestro P; Program in Women's Oncology, Women & Infants Hospital, Providence, RI.
  • Banerjee S; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
  • Colombo N; University of Milan-Bicocca and Istituto Europeo di Oncologia IRCCS, Milan, Italy.
  • Scambia G; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Kim BG; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Friedlander M; University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, New South Wales, Australia.
  • Lisyanskaya A; St Petersburg City Oncology Dispensary, St Petersburg, Russia.
  • Floquet A; Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.
  • Leary A; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Paris, France.
  • Sonke GS; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Paris, France.
  • Gourley C; Institut Gustave-Roussy, Villejuif, France.
  • Oza A; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • González-Martín A; Cancer Research UK Scotland Center, University of Edinburgh, Edinburgh, United Kingdom.
  • Aghajanian C; Princess Margaret Cancer Center, Toronto, ON, Canada.
  • Bradley W; Clínica Universidad de Navarra, Madrid, Spain.
  • Mathews C; Program In Solid Tumours, CIMA, Pamplona, Spain.
  • Liu J; Memorial Sloan Kettering Cancer Center, New York, NY.
  • McNamara J; Froedtert and the Medical College of Wisconsin, Milwaukee, WI.
  • Lowe ES; Program in Women's Oncology, Women & Infants Hospital, Providence, RI.
  • Ah-See ML; Dana-Farber Cancer Institute, Boston, MA.
  • Moore KN; Biostatistics, Oncology Biometrics, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
J Clin Oncol ; 41(3): 609-617, 2023 01 20.
Article en En | MEDLINE | ID: mdl-36082969
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article